RETRACTED: Improvement of non-invasive tests of liver steatosis and fibrosis as indicators for non-alcoholic fatty liver disease in type 2 diabetes mellitus patients with elevated cardiovascular risk profile using the PPAR-α/γ agonist aleglitazar.

Saved in:
Bibliographic Details
Title: RETRACTED: Improvement of non-invasive tests of liver steatosis and fibrosis as indicators for non-alcoholic fatty liver disease in type 2 diabetes mellitus patients with elevated cardiovascular risk profile using the PPAR-α/γ agonist aleglitazar.
Authors: Grobbee EJ; Department of Gastroenterology and Hepatology, Erasmus MC Medical Center, Rotterdam, The Netherlands., de Jong VD; Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Julius Clinical, Zeist, The Netherlands., Schrieks IC; Julius Clinical, Zeist, The Netherlands., Tushuizen ME; Department of Gastroenterology and Hepatology, Leiden University Medical Centre, Leiden, The Netherlands., Holleboom AG; Department of Vascular Medicine, Amsterdam University Medical Center, Amsterdam, The Netherlands., Tardif JC; Montreal Heart Institute Coordinating Center, Université de Montréal, Montreal, Canada., Lincoff AM; Department of Cardiovascular Medicine, Cleveland Clinic Coordinating Center for Clinical Research (C5Research), Cleveland, OH, United States of America., Schwartz GG; Division of Cardiology, VA Medical Center and University of Colorado School of Medicine, Denver, CO, United States of America., Castro Cabezas M; Julius Clinical, Zeist, The Netherlands.; Department of Internal Medicine, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands.; Department of Endocrinology, Erasmus MC Medical Center, Rotterdam, The Netherlands., Grobbee DE; Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Julius Clinical, Zeist, The Netherlands.
Source: PloS one [PLoS One] 2022 Nov 15; Vol. 17 (11), pp. e0277706. Date of Electronic Publication: 2022 Nov 15 (Print Publication: 2022).
Publication Type: Randomized Controlled Trial; Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't; Retracted Publication
Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1932-6203
DOI:10.1371/journal.pone.0277706